SPY305.50-0.05 -0.02%
DIA256.07+0.80 0.31%
IXIC9,482.94-69.11 -0.72%

Protagonist Therapeutics Q1 EPS $(0.720) Misses $(0.690) Estimate

Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.720) per share which missed the analyst consensus estimate of $(0.690) by 4.35 percent. This is a 24.14 percent decrease over losses of $(0.580) per

Benzinga · 05/07/2020 21:31

Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.720) per share which missed the analyst consensus estimate of $(0.690) by 4.35 percent. This is a 24.14 percent decrease over losses of $(0.580) per share from the same period last year.